Your browser doesn't support javascript.
loading
A Note on Preexposure Prophylaxis Preferences Among Women Who Inject Drugs.
Miley, Kerry L; Tran, Nguyen K; Elopre, Latesha; Groves, Allison; Stockman, Jamila K; Bazzi, Angela R; Carrico, Adam; Mazzella, Silvana; Roth, Alexis M.
Affiliation
  • Miley KL; From the Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA.
  • Tran NK; Department of Medicine, Stanford University, Palo Alto, CA.
  • Elopre L; Division of Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Groves A; From the Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA.
  • Stockman JK; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, La Jolla.
  • Bazzi AR; The Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, CA.
  • Carrico A; Department of Public Health Sciences, University of Miami, Miami, FL.
  • Mazzella S; Prevention Point Philadelphia, Philadelphia, PA.
  • Roth AM; From the Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, PA.
Sex Transm Dis ; 50(10): 671-674, 2023 10 01.
Article in En | MEDLINE | ID: mdl-36728264
ABSTRACT
ABSTRACT We informed women who inject drugs about different preexposure prophylaxis (PrEP) formulations; they then ranked their preferences. Daily oral PrEP was most preferred, followed by injectable PrEP and vaginal rings/gels, especially among women of color. Multiple PrEP options should be discussed with women who inject drugs to increase uptake.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis Limits: Female / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis Limits: Female / Humans Language: En Year: 2023 Type: Article